6,327 results on '"OSTEOPETROSIS"'
Search Results
2. Research on Bone Cells in Health and Disease.
- Author
-
Győri, Dávid S.
- Subjects
- *
OSTEOPETROSIS , *C-Jun N-terminal kinases , *BONE cells , *EXTRACELLULAR signal-regulated kinases , *OSTEOCLASTS , *BONE regeneration , *HYPOTHALAMUS , *BONE density - Abstract
The International Journal of Molecular Sciences has published a Special Issue titled "Research on Bone Cells in Health and Disease," which provides new insights into the cellular and molecular mechanisms underlying bone formation and resorption. The issue covers topics such as osteoporosis, osteopetrosis, tumor-induced osteolysis, and inflammatory arthritis-related bone loss. The articles discuss the roles of osteoblasts, osteocytes, and osteoclasts in bone remodeling and the pathogenesis of various bone diseases. The research aims to improve our understanding of bone diseases and develop novel therapies for their treatment. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
3. Rankl genetic deficiency and functional blockade undermine skeletal stem and progenitor cell differentiation.
- Author
-
Schiavone, M. L., Crisafulli, L., Camisaschi, C., De Simone, G., Liberati, F. R., Palagano, E., Rucci, N., Ficara, F., and Sobacchi, Cristina
- Subjects
- *
PROGENITOR cells , *STEM cells , *TRANCE protein , *CELL differentiation , *STROMAL cells , *BONE regeneration , *SYSTEMS biology - Abstract
Background: Skeletal Stem Cells (SSCs) are required for skeletal development, homeostasis, and repair. The perspective of their wide application in regenerative medicine approaches has supported research in this field, even though so far results in the clinic have not reached expectations, possibly due also to partial knowledge of intrinsic, potentially actionable SSC regulatory factors. Among them, the pleiotropic cytokine RANKL, with essential roles also in bone biology, is a candidate deserving deep investigation. Methods: To dissect the role of the RANKL cytokine in SSC biology, we performed ex vivo characterization of SSCs and downstream progenitors (SSPCs) in mice lacking Rankl (Rankl−/−) by means of cytofluorimetric sorting and analysis of SSC populations from different skeletal compartments, gene expression analysis, and in vitro osteogenic differentiation. In addition, we assessed the effect of the pharmacological treatment with the anti-RANKL blocking antibody Denosumab (approved for therapy in patients with pathological bone loss) on the osteogenic potential of bone marrow-derived stromal cells from human healthy subjects (hBMSCs). Results: We found that, regardless of the ossification type of bone, osteochondral SSCs had a higher frequency and impaired differentiation along the osteochondrogenic lineage in Rankl−/− mice as compared to wild-type. Rankl−/− mice also had increased frequency of committed osteochondrogenic and adipogenic progenitor cells deriving from perivascular SSCs. These changes were not due to the peculiar bone phenotype of increased density caused by lack of osteoclast resorption (defined osteopetrosis); indeed, they were not found in another osteopetrotic mouse model, i.e., the oc/oc mouse, and were therefore not due to osteopetrosis per se. In addition, Rankl−/− SSCs and primary osteoblasts showed reduced mineralization capacity. Of note, hBMSCs treated in vitro with Denosumab had reduced osteogenic capacity compared to control cultures. Conclusions: We provide for the first time the characterization of SSPCs from mouse models of severe recessive osteopetrosis. We demonstrate that Rankl genetic deficiency in murine SSCs and functional blockade in hBMSCs reduce their osteogenic potential. Therefore, we propose that RANKL is an important regulatory factor of SSC features with translational relevance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Severely Displaced Fracture on Pediatric Osteopetrosis Patient: A Case Report.
- Author
-
Yudyanda, Dimas Rangga and Martanto, Tri Wahyu
- Abstract
Osteopetrosis, a rare bone disorder, causes unusually dense bones due to impaired bone resorption by osteoclasts, termed osteosclerosis. Symptoms vary by type and severity, marked by thickened and rigid bones. A 12-year-old boy complained of left thigh pain after falling into a sewer, previously treated for a right thigh fracture with open reduction and internal fixation (ORIF). ORIF is crucial for managing acute and osteopetrotic fractures, emphasizing screw-plate fixation to prevent drilling into non-medullated bone. The disorder's bone stiffness complicates surgery, requiring higher drilling pressure and risking necrosis. In summary, managing severely displaced osteopetrotic bone fractures with ORIF yielded satisfactory results. While effective, open reduction and internal fixation require careful consideration of technical challenges and potential complications. Specific surgical strategies can lead to successful outcomes in osteopetrosis patients, emphasizing the importance of increased diagnostic awareness. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Multisystem disorder associated with a pathogenic variant in CLCN7 in the absence of osteopetrosis.
- Author
-
Lee, Chung‐Lin, Chang, Yeun‐Wen, Lin, Hsiang‐Yu, Lee, Hung‐Chang, Yeh, Ting‐Chi, Fang, Li‐Ching, Lee, Ni‐Chung, Tsai, Jeng‐Daw, and Lin, Shuan‐Pei
- Subjects
- *
OSTEOPETROSIS , *DEVELOPMENTAL delay , *AGAMMAGLOBULINEMIA , *DRUG target , *PHENOTYPES - Abstract
Background: We clinically and genetically evaluated a Taiwanese boy presenting with developmental delay, organomegaly, hypogammaglobulinemia and hypopigmentation without osteopetrosis. Whole‐exome sequencing revealed a de novo gain‐of‐function variant, p.Tyr715Cys, in the C‐terminal domain of ClC‐7 encoded by CLCN7. Methods: Nicoli et al. (2019) assessed the functional impact of p.Tyr715Cys by heterologous expression in Xenopus oocytes and evaluating resulting currents. Results: The variant led to increased outward currents, indicating it underlies the patient's phenotype of lysosomal hyperacidity, storage defects and vacuolization. This demonstrates the crucial physiological role of ClC‐7 antiporter activity in maintaining appropriate lysosomal pH. Conclusion: Elucidating mechanisms by which CLCN7 variants lead to lysosomal dysfunction will advance understanding of genotype–phenotype correlations. Identifying modifier genes and compensatory pathways may reveal therapeutic targets. Ongoing functional characterization of variants along with longitudinal clinical evaluations will continue advancing knowledge of ClC‐7's critical roles and disease mechanisms resulting from its dysfunction. Expanded cohort studies are warranted to delineate the full spectrum of associated phenotypes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Refractory maxillary osteomyelitis with osteopetrosis: A case report.
- Author
-
Murai, Chika, Sakata, Ken-ichiro, Nakamura, Keisuke, Yoshikawa, Kazuhito, Sato, Jun, Matsuda, Aya, and Kitagawa, Yoshimasa
- Abstract
In osteopetrosis, refractory jawbone osteomyelitis often occurs because of the progression of bone sclerosis, which makes the bone brittle. Herein, we report a case of refractory osteopetrosis-related maxillary osteomyelitis for which conservative therapy and surgical intervention were performed along with imaging evaluation. A 58-year-old woman had maxillary gingivitis for 2 years, for which her tooth was recently extracted. Subsequently, she developed sequestration and oroantral fistula and visited our department. Panoramic radiography, computed tomography, and magnetic resonance imaging (MRI) scans revealed left maxillary osteomyelitis, sinusitis, and sequestration. She had been diagnosed with osteopetrosis in childhood and exhibited sclerotic changes, which were likely caused by osteopetrosis. Bone scintigraphy using Tc-99m-HMDP revealed no increase in tracer uptake in the jawbone. Finally, the patient was diagnosed with osteopetrosis-related left maxillary osteomyelitis and sinusitis; hence, she underwent hyperbaric oxygen therapy, multiple surgeries, and antibiotic therapy. Hepatic dysfunction occurred during the treatment, and a mediastinal tumor was suspected. Thus, fluorodeoxyglucose-positron emission tomography was performed. Further, the patient was diagnosed with extramedullary hematopoietic foci associated with osteopetrosis and hepatic dysfunction due to hepatitis B, there was no Tc-99m accumulation in the maxilla, and hepatitis was treated concurrently. Six months after the final surgery for osteomyelitis, antibiotic therapy was discontinued. Notably, 2 years have passed without exacerbation of osteomyelitis. Moreover, bone scintigraphy using Tc-99m-HMDP did not reveal increased Tc-99m accumulation in the jawbone. In cases of osteopetrosis-related osteomyelitis, interpretation of findings should be done cautiously because Tc-99m may accumulate in an area with active bone metabolism and osteomyelitis may be masked. Refractory osteomyelitis with osteopetrosis requires careful interpretation of MRI and bone scintigraphy scans, and long-term follow-up is required. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Molecular Heterogeneity of Osteopetrosis in India: Report of 17 Novel Variants.
- Author
-
Arunachalam, Arun Kumar, Aboobacker, Fouzia N., Sampath, Eswari, Devasia, Anup J., Korula, Anu, George, Biju, and Edison, Eunice Sindhuvi
- Abstract
Osteopetrosis is a clinically and genetically heterogeneous group of inherited bone disorders that is caused by defects in osteoclast formation or function. Treatment options vary with the disease severity and an accurate molecular diagnosis helps in prognostication and treatment decisions. We investigated the genetic causes of osteopetrosis in 31 unrelated patients of Indian origin. Screening for the genetic variants was done by Sanger sequencing or next generation sequencing in 48 samples that included 31 samples from index patients, 16 from parents' and 1 chorionic villus sample. A total of 30 variants, including 29 unique variants, were identified in 26 of the 31 patients in the study. TCIRG1 was the most involved gene (n = 14) followed by TNFRSF11A (n = 4) and CLCN7 (n = 3). A total of 17 novel variants were identified. Prenatal diagnosis was done in one family and the foetus showed homozygous c.807 + 2T > G variant in TCIRG1. Molecular diagnosis of osteopetrosis aids in therapeutic decisions including the need for a stem cell transplantation and gives a possible option of performing prenatal diagnosis in affected families. Further studies would help in understanding the genetic etiology in patients where no variants were identified. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene.
- Author
-
Jodeh, Wade, Katz, Amy J, Hart, Marian, Warden, Stuart J, Niziolek, Paul, Alam, Imranul, Ing, Steven, Polgreen, Lynda E, Imel, Erik A, and Econs, Michael J
- Subjects
MISSENSE mutation ,OSTEOPETROSIS ,GENETIC variation ,RECESSIVE genes ,PHENOTYPIC plasticity ,CHLORIDE channels ,FRACTURE healing ,T cells - Abstract
Context Autosomal dominant osteopetrosis (ADO) is a rare genetic disorder resulting from impaired osteoclastic bone resorption. Clinical manifestations frequently include fractures, osteonecrosis (particularly of the jaw or maxilla), osteomyelitis, blindness, and/or bone marrow failure. ADO usually results from heterozygous missense variants in the Chloride Channel 7 gene (CLCN7) that cause disease by a dominant negative mechanism. Variants in the T-cell immune regulator 1 gene (TCIRG1) are commonly identified in autosomal recessive osteopetrosis but have only been reported in 1 patient with ADO. Case Description Here, we report 3 family members with a single heterozygous missense variant (p.Gly579Arg) in TCIRG1 who have a phenotype consistent with ADO. Three of 5 protein prediction programs suggest this variant likely inhibits the function of TCIRG1. Conclusion This is the first description of adult presentation of ADO caused by a TCIRG1 variant. Similar to families with ADO from CLCN7 mutations, this variant in TCIRG1 results in marked phenotype variability, with 2 subjects having severe disease and the third having very mild disease. This family report implicates TCIRG1 missense mutations as a cause of ADO and demonstrates that the marked phenotypic variability in ADO may extend to disease caused by TCIRG1 missense mutations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Rankl genetic deficiency and functional blockade undermine skeletal stem and progenitor cell differentiation
- Author
-
M. L. Schiavone, L. Crisafulli, C. Camisaschi, G. De Simone, F. R. Liberati, E. Palagano, N. Rucci, F. Ficara, and Cristina Sobacchi
- Subjects
RANKL ,Skeletal stem cells ,Differentiation ,Osteopetrosis ,Denosumab ,Therapy ,Medicine (General) ,R5-920 ,Biochemistry ,QD415-436 - Abstract
Abstract Background Skeletal Stem Cells (SSCs) are required for skeletal development, homeostasis, and repair. The perspective of their wide application in regenerative medicine approaches has supported research in this field, even though so far results in the clinic have not reached expectations, possibly due also to partial knowledge of intrinsic, potentially actionable SSC regulatory factors. Among them, the pleiotropic cytokine RANKL, with essential roles also in bone biology, is a candidate deserving deep investigation. Methods To dissect the role of the RANKL cytokine in SSC biology, we performed ex vivo characterization of SSCs and downstream progenitors (SSPCs) in mice lacking Rankl (Rankl −/− ) by means of cytofluorimetric sorting and analysis of SSC populations from different skeletal compartments, gene expression analysis, and in vitro osteogenic differentiation. In addition, we assessed the effect of the pharmacological treatment with the anti-RANKL blocking antibody Denosumab (approved for therapy in patients with pathological bone loss) on the osteogenic potential of bone marrow-derived stromal cells from human healthy subjects (hBMSCs). Results We found that, regardless of the ossification type of bone, osteochondral SSCs had a higher frequency and impaired differentiation along the osteochondrogenic lineage in Rankl −/− mice as compared to wild-type. Rankl −/− mice also had increased frequency of committed osteochondrogenic and adipogenic progenitor cells deriving from perivascular SSCs. These changes were not due to the peculiar bone phenotype of increased density caused by lack of osteoclast resorption (defined osteopetrosis); indeed, they were not found in another osteopetrotic mouse model, i.e., the oc/oc mouse, and were therefore not due to osteopetrosis per se. In addition, Rankl −/− SSCs and primary osteoblasts showed reduced mineralization capacity. Of note, hBMSCs treated in vitro with Denosumab had reduced osteogenic capacity compared to control cultures. Conclusions We provide for the first time the characterization of SSPCs from mouse models of severe recessive osteopetrosis. We demonstrate that Rankl genetic deficiency in murine SSCs and functional blockade in hBMSCs reduce their osteogenic potential. Therefore, we propose that RANKL is an important regulatory factor of SSC features with translational relevance.
- Published
- 2024
- Full Text
- View/download PDF
10. Applied Basic Science
- Author
-
Abdul Hameed, Shamsi, Mathai, Naveen Joseph, Mudawi, Aiman, editor, Fuad, Mazhar, editor, Abdul Hameed, Shamsi, editor, and Al-Dosari, Mohd Al-Ateeq, editor
- Published
- 2024
- Full Text
- View/download PDF
11. MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
- Published
- 2023
12. ACTIMMUNE in Intermediate Osteopetrosis
- Author
-
University of Minnesota and Horizon Pharma Ireland, Ltd., Dublin Ireland
- Published
- 2023
13. Osteopetrosis complicated by multilevel spondylolysis
- Author
-
William W. Pryor, III, MD, Carolina V. Guimaraes, MD, and Lane F. Donnelly, MD
- Subjects
Multilevel spondylolysis ,Osteopetrosis ,CLCN7 (chloride voltage-gated channel 7) ,TCIRG1 (T cell immune regulator 1) ,LRP5 (low-density lipoprotein receptor-related protein 5) ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Osteopetrosis is a heterogenous group of inheritable disorders which manifests as increased bone density and brittleness. The most common and mildest variant typically presents in adulthood with bone pain and pathologic fractures, including spondylolysis. We present the case of an otherwise healthy, active 17-year-old male with a history of osteopetrosis and 1 year of chronic back pain, found to have multilevel (L1–L4) spondylolysis in the setting of severe diffuse bony sclerosis consistent with osteopetrosis. While single-level spondylolysis is an uncommon complication of osteopetrosis, multilevel spondylolysis in the pediatric population is extremely rare and the genetics of prior cases studies have not been reported. Spondylolysis should be considered as one of the types of fractures that may occur in patients with osteopetrosis.
- Published
- 2024
- Full Text
- View/download PDF
14. Osteopetrosis in the pediatric patient: what the radiologist needs to know.
- Author
-
McLuckey, Morgan N., Imel, Erik A., and Forbes-Amrhein, Monica M.
- Subjects
- *
CHILD patients , *OSTEOPETROSIS , *RADIOLOGISTS , *GENETIC disorders , *ADULTS - Abstract
Osteopetrosis describes several types of rare sclerosing bone dysplasias of varying clinical and radiographic severity. The classic autosomal dominant subtype emerges most often in adolescence but can present from infancy through adulthood. The autosomal recessive osteopetrosis, or "malignant infantile osteopetrosis," presents in infancy with a grimmer prognosis, though the autosomal dominant forms (often mislabeled as "benign") actually can have life-threatening consequences as well. Often osteopetrosis is detected due to skeletal findings on radiographs performed to evaluate injury or as an incidental finding during evaluation for illness. Given the varied phenotypic severity and presentations at different ages, radiologists play an integral role in the care of these patients both in diagnosis and in clinical evaluation and monitoring. A deeper understanding of the underlying genetic basis of the disease can aid in the radiologist in diagnosis and in anticipation of unique complications. An overview of current clinical management is also discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Allogenic hematopoietic stem cell transplantation in an Iranian patient with osteopetrosis caused by carbonic anhydrase II deficiency: A case report.
- Author
-
Shamsian, Bibi Shahin, Momtazmanesh, Nader, Saneifard, Hedyeh, Tabatabaei, Seyed Mohammad Taghi Hosseini, Jafari, Mohammadreza, pour, Zahra Khafaf, Al‐Hussieni, Kawthar Jasim Mohammad Rida, Jamee, Mahnaz, and Kamfar, Sharareh
- Subjects
- *
HEMATOPOIETIC stem cell transplantation , *CARBONIC anhydrase , *OSTEOPETROSIS , *RENAL tubular transport disorders , *PROGNOSIS , *BLOOD cell count - Abstract
Background: Osteopetrosis is a group of geneticall heterogeneous disorders resulting from impaired osteoclast function and bone resorption. The identification of specific genetic mutations can yield important prognostic and therapeutic implications. Herein, we present the diagnosis and successful application of hematopoietic stem cell transplantation (HSCT) in a patient with osteopetrosis caused by carbonic anhydrase II deficiency (Intermediate osteopetrosis). Case Presentation: Herein, we describe a 2.5‐year‐old male patient born to consanguineous parents who presented at 8‐month‐old with hydrocephaly, brain shunt, and developmental delay. Later at 9 months old, he was found to have eye disorder such as nystagmus, fracture of the elbow, abnormal skeletal survey, normal cell blood count (CBC), and severe hypocellularity in the bone marrow. Further evaluation showed renal tubular acidosis type 2. Whole‐exome sequencing revealed a pathogenic homozygous variant in intron 2 of the carbonic anhydrase 2 gene (CA2) gene (c.232 + 1 G>T). The diagnosis of intermediate autosomal recessive osteopetrosis was established, and allogenic HSCT from his mother, a full‐matched related donor (MRD), was planned. The conditioning regimen included Busulfan, Fludarabine, and Rabbit anti‐thymocyte globulin. Cyclosporine and Mycophenolate Mofetil were used for graft‐versus‐host‐disease prophylaxis. He Engrafted on day +13, and 95% chimerism was achieved. He is currently doing well without immunosuppressive therapy, now 12 months post HSCT, with normal calcium level and improving visual quality and FISH analysis revealed complete donor chimerism. Discussion: HSCT could be a promising curative treatment for intermediate osteopetrosis and can provide long‐term survival. Ongoing challenges in various aspects of HSCT remain to be addressed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction.
- Author
-
Hong, Jung Min, Gerard-O'Riley, Rita L., Acton, Dena, Alam, Imranul, Econs, Michael J., and Bruzzaniti, Angela
- Subjects
- *
PHOSPHODIESTERASE inhibitors , *FORSKOLIN , *ADENYLATE cyclase , *CHLORIDE channels , *BONE resorption , *MISSENSE mutation , *ANIMAL rescue - Abstract
Autosomal Dominant Osteopetrosis type II (ADO2) is a rare bone disease of impaired osteoclastic bone resorption caused by heterozygous missense mutations in the chloride channel 7 (CLCN7). Adenylate cyclase, which catalyzes the formation of cAMP, is critical for lysosomal acidification in osteoclasts. We found reduced cAMP levels in ADO2 osteoclasts compared to wild-type (WT) osteoclasts, leading us to examine whether regulating cAMP would improve ADO2 osteoclast activity. Although forskolin, a known activator of adenylate cyclase and cAMP levels, negatively affected osteoclast number, it led to an overall increase in ADO2 and WT osteoclast resorption activity in vitro. Next, we examined cAMP hydrolysis by the phosphodiesterase 4 (PDE4) proteins in ADO2 versus WT osteoclasts. QPCR analysis revealed higher expression of the three major PDE4 subtypes (4a, 4b, 4d) in ADO2 osteoclasts compared in WT, consistent with reduced cAMP levels in ADO2 osteoclasts. In addition, we found that the PDE4 antagonists, rolipram and roflumilast, stimulated ADO2 and WT osteoclast formation in a dose-dependent manner. Importantly, roflumilast and rolipram displayed a concentration-dependent increase in osteoclast resorption activity which was greater in ADO2 than WT osteoclasts. Moreover, treatment with roflumilast rescued cAMP levels in ADO2 OCLs. The key findings from our studies demonstrate that osteoclasts from ADO2 mice exhibit reduced cAMP levels and PDE4 inhibition rescues cAMP levels and ADO2 osteoclast activity dysfunction in vitro. The mechanism of action of PDE4 inhibitors and their ability to reduce the high bone mass of ADO2 mice in vivo are currently under investigation. Importantly, these studies advance the understanding of the mechanisms underlying the ADO2 osteoclast dysfunction which is critical for the development of therapeutic approaches to treat clinically affected ADO2 patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Effect of Roflumilast, a Selective PDE4 Inhibitor, on Bone Phenotypes in ADO2 Mice.
- Author
-
Alam, Imranul, Hardman, Sara L., Gerard-O'Riley, Rita L., Acton, Dena, Parker, Reginald S., Hong, Jung Min, Bruzzaniti, Angela, and Econs, Michael J.
- Subjects
- *
BONE resorption , *BONE density , *CHLORIDE channels , *PHENOTYPES , *MICE , *BONE diseases , *RECTUS femoris muscles , *FEMUR - Abstract
Autosomal Dominant Osteopetrosis type II (ADO2) is a rare bone disease of impaired osteoclastic bone resorption that usually results from heterozygous missense mutations in the chloride channel 7 (CLCN7) gene. We previously created mouse models of ADO2 (p.G213R) with one of the most common mutations (G215R) as found in humans and demonstrated that this mutation in mice phenocopies the human disease of ADO2. Previous studies have shown that roflumilast (RF), a selective phosphodiesterase 4 (PDE4) inhibitor that regulates the cAMP pathway, can increase osteoclast activity. We also observed that RF increased bone resorption in both wild-type and ADO2 heterozygous osteoclasts in vitro, suggesting it might rescue bone phenotypes in ADO2 mice. To test this hypothesis, we administered RF-treated diets (0, 20 and 100 mg/kg) to 8-week-old ADO2 mice for 6 months. We evaluated bone mineral density and bone micro-architecture using longitudinal in-vivo DXA and micro-CT at baseline, and 6-, 12-, 18-, and 24-week post-baseline time points. Additionally, we analyzed serum bone biomarkers (CTX, TRAP, and P1NP) at baseline, 12-, and 24-week post-baseline. Our findings revealed that RF treatment did not improve aBMD (whole body, femur, and spine) and trabecular BV/TV (distal femur) in ADO2 mice compared to the control group treated with a normal diet. Furthermore, we did not observe any significant changes in serum levels of bone biomarkers due to RF treatment in these mice. Overall, our results indicate that RF does not rescue the osteopetrotic bone phenotypes in ADO2 heterozygous mice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Current knowledge of bone-derived factor osteocalcin: its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis and inflammatory joint diseases.
- Author
-
Martiniakova, Monika, Biro, Roman, Kovacova, Veronika, Babikova, Martina, Zemanova, Nina, Mondockova, Vladimira, and Omelka, Radoslav
- Subjects
- *
JOINT diseases , *OSTEOPETROSIS , *OSTEOCHONDROSIS , *DIABETES , *TYPE 2 diabetes , *OSTEOCALCIN - Abstract
Osteocalcin (OC) is the most abundant non-collagenous and osteoblast-secreted protein in bone. It consists of two forms such as carboxylated OC (cOC) and undercarboxylated OC (ucOC). While cOC promotes bone mineralization and increases bone strength, ucOC is regarded an endocrinologically active form that may have several functions in multiple end organs and tissues. Total OC (tOC) includes both of these forms (cOC and ucOC) and is considered a marker of bone turnover in clinical settings. Most of the data on OC is limited to preclinical studies and therefore may not accurately reflect the situation in clinical conditions. For the stated reason, the aim of this review was not only to summarize current knowledge of all forms of OC and characterize its role in diabetes mellitus, osteoporosis, osteopetrosis, inflammatory joint diseases, but also to provide new interpretations of its involvement in the management and treatment of aforementioned diseases. In this context, special emphasis was placed on available clinical trials. Significantly lower levels of tOC and ucOC could be associated with the risk of type 2 diabetes mellitus. On the contrary, tOC level does not seem to be a good indicator of high bone turnover status in postmenopausal osteoporosis, osteoarthritis and rheumatoid arthritis. The associations between several pharmacological drugs used to treat all disorders mentioned above and OC levels have also been provided. From this perspective, OC may serve as a medium through which certain medications can influence glucose metabolism, body weight, adiponectin secretion, and synovial inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Osteopetrorickets: two contradictory patterns—one unifying diagnosis.
- Author
-
Behr, Gerald, Kuhn, Marlena, Oved, Joseph H., and Sulis, Maria Luisa
- Subjects
- *
SYMPTOMS , *DELAYED diagnosis , *RICKETS , *DIAGNOSIS , *OSTEOPETROSIS - Abstract
A 5-month-old infant with bone findings on x-ray presented an apparent contradiction including findings of both diffusely dense bones and rickets in the context of a history and laboratory investigation that suggested leukemia. Next generation gene panel sequencing revealed a TCIRG1 mutation which is consistent with autosomal recessive osteopetrosis. The paradoxical x-ray findings underscore a recently elucidated mechanism for the pathogenesis of a TCIRG mutation. This case highlights the importance of recognizing this radiographic, seeming contradictory, association in the context of a confusing clinical presentation. Failure to recognize this pattern promptly may lead to a delay in diagnosis, thus potentially permanent organ failure. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Correction of osteopetrosis in the neonate oc/oc murine model after lentiviral vector gene therapy and non-genotoxic conditioning
- Author
-
Sara Penna, Alessandra Zecchillo, Martina Di Verniere, Elena Fontana, Valeria Iannello, Eleonora Palagano, Stefano Mantero, Andrea Cappelleri, Elena Rizzoli, Ludovica Santi, Laura Crisafulli, Marta Filibian, Antonella Forlino, Luca Basso-Ricci, Serena Scala, Eugenio Scanziani, Thorsten Schinke, Francesca Ficara, Cristina Sobacchi, Anna Villa, and Valentina Capo
- Subjects
gene therapy ,osteopetrosis ,lentiviral vector ,osteoclast ,hematopoietic stem cells ,HSC mobilization ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
IntroductionAutosomal recessive osteopetrosis (ARO) is a rare genetic disease, characterized by increased bone density due to defective osteoclast function. Most of the cases are due to TCIRG1 gene mutation, leading to severe bone phenotype and death in the first years of life. The standard therapy is the hematopoietic stem cell transplantation (HSCT), but its success is limited by several constraints. Conversely, gene therapy (GT) could minimize the immune-mediated complications of allogeneic HSCT and offer a prompt treatment to these patients.MethodsThe Tcirg1-defective oc/oc mouse model displays a short lifespan and high bone density, closely mirroring the human condition. In this work, we exploited the oc/oc neonate mice to optimize the critical steps for a successful therapy.ResultsFirst, we showed that lentiviral vector GT can revert the osteopetrotic bone phenotype, allowing long-term survival and reducing extramedullary haematopoiesis. Then, we demonstrated that plerixafor-induced mobilization can further increase the high number of HSPCs circulating in peripheral blood, facilitating the collection of adequate numbers of cells for therapeutic purposes. Finally, pre-transplant non-genotoxic conditioning allowed the stable engraftment of HSPCs, albeit at lower level than conventional total body irradiation, and led to long-term survival and correction of bone phenotype, in the absence of acute toxicity.ConclusionThese results will pave the way to the implementation of an effective GT protocol, reducing the transplant-related complication risks in the very young and severely affected ARO patients.
- Published
- 2024
- Full Text
- View/download PDF
21. Infantile osteopetrosis with delayed development, organomegaly and wandering eyes: case report.
- Author
-
Prithvi, Ashwini, Kodethoor, Dhrithi, K, Sushma, and Lewin, Sanjiv
- Subjects
- *
OSTEOPETROSIS , *METABOLIC bone disorders , *SYMPTOMS , *DEVELOPMENTAL delay , *EYE movements , *FAILURE to thrive syndrome - Abstract
Osteopetrosis encompasses rare inherited metabolic bone disorders with defect in the osteoclast activity. Severe forms of presentation such as malignant infantile osteopetrosis are seen in infants and milder forms in older children. The clinical presentation includes failure to thrive, severe pallor, optic atrophy and hepatosplenomegaly. The disorder is characterised by dense bone on radiography, hence the name marble bone disease. A 10-month-old boy who presented with developmental delay, failure to thrive, nystagmus (which the mother described as wandering eye movements), splenomegaly of 16 cm and hepatomegaly of 8 cm. Investigations demonstrated severe anaemia (5.7 g/dL) and thrombocytopenia (34 x 109/L). Radiological signs which help in the diagnosis include diffuse sclerosis, bone within bone appearance, sandwich vertebrae and Erlenmeyer flask deformity. Plain radiography is an easily available and cost effective tool which can aid in the diagnosis of osteopetrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
- Published
- 2023
23. Concurrent Malignant Infantile Osteopetrosis and Hypophosphatasia in a Six-year-old Boy: A Case Report
- Author
-
Kong, Tracie Y and Ghahremani Koureh, Shahnaz
- Subjects
osteopetrosis ,malignant infantile osteopetrosis ,hypophosphatasia - Abstract
Malignant infantile osteopetrosis is a rare inherited disease of bone metabolism, in which osteoclast dysfunction and diminished bone turnover lead to diffuse sclerosis with obliteration of the medullary cavities and narrowing of the skull base neural foramina. We report a case of malignant infantile osteopetrosis with bone marrow failure and optic atrophy that co-occurred with hypophosphatasia, another rare inherited bone disease, in a 6-year-old boy. Key imaging signs of these rare diseases are discussed.
- Published
- 2023
24. A Case of Osteopetrosis with Orbital Inflammation Secondary to Maxillary Osteomyelitis
- Author
-
Takafumi Misaki, Fumiko Murao, Kayo Shinomiya, Akihiro Tani, Masayuki Yamada, and Yoshinori Mitamura
- Subjects
osteopetrosis ,maxillary osteomyelitis ,orbital inflammation ,caries ,periostitis ,Ophthalmology ,RE1-994 - Abstract
Introduction: Osteopetrosis is a rare heritable disorder characterized by increased bone density resulting from osteoclast dysfunction. Major complications include bone fracture, osteomyelitis, anemia, and cranial nerve compression. Optic atrophy can occur due to compression of the optic nerve. Although osteomyelitis of the jaw is a common complication, it rarely occurs in the maxilla. Here, we report a case of a 74-year-old female with osteopetrosis who developed maxillary osteomyelitis, leading to orbital inflammation. Case Presentation: She was referred to our clinic for 2 months of ptosis and swelling of the left eyelid and temporal region. Previous imaging revealed a left intraorbital occupying lesion, but a biopsy of the temporal subcutaneous tissue did not provide a definitive diagnosis. After 7 months, she presented with severe temporal swelling and purulent discharge. Upon examination, maxillary osteomyelitis resulting from caries of the upper jaw was observed. Treatment with oral antibiotics, drainage of the temporal skin fistula, and regular cleaning of the maxillary drainage improved her symptoms. Conclusion: This is a rare case of maxillary osteomyelitis associated with osteopetrosis, causing orbital inflammation.
- Published
- 2024
- Full Text
- View/download PDF
25. Osteopetrosis with Typical Radiological Findings: A Report of a Rare Case.
- Author
-
Kibrom, Bethlehem Tesfasilassie, Feleke, Tesfahunegn Hailemariam, Admasu, Wubineh, Tsegaye, Frehiwot, and Hailu, Samuel Sisay
- Subjects
- *
OSTEOPETROSIS , *BONE resorption , *GENETIC disorders , *BONE marrow , *GENETIC testing - Abstract
BACKGROUND: Osteopetrosis is a rare inherited disease caused by a lack of osteoclastic bone resorption, resulting in increased bone mass with insufficient mechanical strength. Patients usually present with complications such as pathologic fractures, cranial neuropathies, and bone marrow failure. Diagnosis is based on suggestive clinical and imaging findings, with genetic testing to confirm diagnosis and identify the subtype. CASE PRESENTATION: The patient is an eight-year-old girl who came to our hospital with complaints of bilateral arm swelling and visual disturbances for four years and a history of fracture of the left lower extremity two years before presentation. Physical examination revealed nontender bilateral arm swelling and a shorter left leg. The laboratory tests were within normal limits. A skeletal radiograph showed typical radiographic features of osteopetrosis. CONCLUSION: It is important to consider osteopetrosis in patients presenting with pathologic fractures and cranial neuropathies. Typical imaging findings can provide rapid diagnosis in severe cases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. The Cl- transporter ClC-7 is essential for phagocytic clearance by microglia.
- Author
-
Iyer, Harini and Talbot, William S.
- Subjects
- *
MICROGLIA , *MEMBRANE proteins , *MACROPHAGES , *OSTEOPETROSIS , *NEURONS , *BIOINFORMATICS - Abstract
Microglia, professional phagocytic cells of the brain, rely upon the appropriate activation of lysosomes to execute their immune and clearance functions. Lysosomal activity is, in turn, modulated by a complex network of over 200 membrane and accessory proteins that relay extracellular cues to these key degradation centers. The ClC-7 chloride (Cl-)-proton (H+) antiporter (also known as CLCN7) is localized to the endolysosomal compartments and mutations in CLCN7 lead to osteopetrosis and neurodegeneration. Although the functions of ClC-7 have been extensively investigated in osteoclasts and neurons, its role in microglia in vivo remains largely unexamined. Here, we show that microglia and embryonic macrophages in zebrafish clcn7 mutants cannot effectively process extracellular debris in the form of apoptotic cells and β-amyloid. Despite these functional defects, microglia develop normally in clcn7mutants and display normal expression of endosomal and lysosomal markers. We also find that mutants for ostm1, which encodes the β-subunit of ClC-7, have a phenotype that is strikingly similar to that of clcn7 mutants. Together, our observations uncover a previously unappreciated role of ClC-7 inmicroglia and contribute to the understanding of the neurodegenerative phenotypes that accompany mutations in this channel. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src.
- Author
-
Li, Zhenxi, Yang, Xinghai, Fu, Ruifeng, Wu, Zhipeng, Xu, Shengzhao, Jiao, Jian, Qian, Ming, Zhang, Long, Wu, Chunbiao, Xie, Tianying, Yao, Jiqiang, Wu, Zhixiang, Li, Wenjun, Ma, Guoli, You, Yu, Chen, Yihua, Zhang, Han-kun, Cheng, Yiyun, Tang, Xiaolong, and Wu, Pengfei
- Subjects
KISSPEPTINS ,OSTEOCLASTS ,BONE resorption ,KNOCKOUT mice ,OSTEOPETROSIS - Abstract
Osteoclasts are over-activated as we age, which results in bone loss. Src deficiency in mice leads to severe osteopetrosis due to a functional defect in osteoclasts, indicating that Src function is essential in osteoclasts. G-protein-coupled receptors (GPCRs) are the targets for ∼35% of approved drugs but it is still unclear how GPCRs regulate Src kinase activity. Here, we reveal that GPR54 activation by its natural ligand Kisspeptin-10 (Kp-10) causes Dusp18 to dephosphorylate Src at Tyr 416. Mechanistically, Gpr54 recruits both active Src and the Dusp18 phosphatase at its proline/arginine-rich motif in its C terminus. We show that Kp-10 binding to Gpr54 leads to the up-regulation of Dusp18. Kiss1, Gpr54 and Dusp18 knockout mice all exhibit osteoclast hyperactivation and bone loss, and Kp-10 abrogated bone loss by suppressing osteoclast activity in vivo. Therefore, Kp-10/Gpr54 is a promising therapeutic target to abrogate bone resorption by Dusp18-mediated Src dephosphorylation. The authors of this manuscript identify that Gpr54 activation by its natural ligand Kisspeptin-10 can abrogate bone resorption. Mechanistically, Gpr54 recruits both active Src and the Dusp18 phosphatase, which causes Dusp18 to dephosphorylate Src at Tyr 416. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Sensitivity Analysis of Upper Limb Musculoskeletal Models During Isometric and Isokinetic Tasks.
- Author
-
Diaz, Maximillian T., Harley, Joel B., and Nichols, Jennifer A.
- Subjects
- *
SENSITIVITY analysis , *OSTEOPETROSIS , *PREDICTION models , *DIAGNOSTIC imaging - Abstract
Sensitivity coefficients are used to understand how errors in subject-specific musculoskeletal model parameters influence model predictions. Previous sensitivity studies in the lower limb calculated sensitivity using perturbations that do not fully represent the diversity of the population. Hence, the present study performs sensitivity analysis in the upper limb using a large synthetic dataset to capture greater physiological diversity. The large dataset (n = 401 synthetic subjects) was created by adjusting maximum isometric force, optimal fiber length, pennation angle, and bone mass to induce atrophy, hypertrophy, osteoporosis, and osteopetrosis in two upper limb musculoskeletal models. Simulations of three isometric and two isokinetic upper limb tasks were performed using each synthetic subject to predict muscle activations. Sensitivity coefficients were calculated using three different methods (two point, linear regression, and sensitivity functions) to understand how changes in Hill-type parameters influenced predicted muscle activations. The sensitivity coefficient methods were then compared by evaluating how well the coefficients accounted for measurement uncertainty. This was done by using the sensitivity coefficients to predict the range of muscle activations given known errors in measuring musculoskeletal parameters from medical imaging. Sensitivity functions were found to best account for measurement uncertainty. Simulated muscle activations were most sensitive to optimal fiber length and maximum isometric force during upper limb tasks. Importantly, the level of sensitivity was muscle and task dependent. These findings provide a foundation for how large synthetic datasets can be applied to capture physiologically diverse populations and understand how model parameters influence predictions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. A Case of Osteopetrosis with Orbital Inflammation Secondary to Maxillary Osteomyelitis.
- Author
-
Misaki, Takafumi, Murao, Fumiko, Shinomiya, Kayo, Tani, Akihiro, Yamada, Masayuki, and Mitamura, Yoshinori
- Subjects
- *
OSTEOPETROSIS , *MAXILLA , *OSTEOMYELITIS , *TEMPORAL lobe , *BONE density , *INFLAMMATION - Abstract
Introduction: Osteopetrosis is a rare heritable disorder characterized by increased bone density resulting from osteoclast dysfunction. Major complications include bone fracture, osteomyelitis, anemia, and cranial nerve compression. Optic atrophy can occur due to compression of the optic nerve. Although osteomyelitis of the jaw is a common complication, it rarely occurs in the maxilla. Here, we report a case of a 74-year-old female with osteopetrosis who developed maxillary osteomyelitis, leading to orbital inflammation. Case Presentation: She was referred to our clinic for 2 months of ptosis and swelling of the left eyelid and temporal region. Previous imaging revealed a left intraorbital occupying lesion, but a biopsy of the temporal subcutaneous tissue did not provide a definitive diagnosis. After 7 months, she presented with severe temporal swelling and purulent discharge. Upon examination, maxillary osteomyelitis resulting from caries of the upper jaw was observed. Treatment with oral antibiotics, drainage of the temporal skin fistula, and regular cleaning of the maxillary drainage improved her symptoms. Conclusion: This is a rare case of maxillary osteomyelitis associated with osteopetrosis, causing orbital inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Implant strategies for femur fractures in osteopetrosis: Insights from a case series and literature review
- Author
-
Sivakumar S.P., Sindhura Yamajala, Nagashree Vasudeva, Dheenadhayalan Jayaramaraju, and Rajasekaran Shanmuganathan
- Subjects
Osteopetrosis ,Femur fracture ,Subtrochanteric fracture ,Intramedullary nailing ,Nail plate construct ,Orthopedic surgery ,RD701-811 - Abstract
Background: A rare category of hereditary illnesses known as osteopetrosis (OP) causes increased bone radiodensity on radiographs. Due to brittle bone and frequent fractures, symptomatic management is the mainstay of treatment. The underlying pathology of osteopetrosis in a patient presenting with long bone fractures may be missed due to the rarity of the condition and lack of awareness on the part of the treating surgeon. There is no consensus on fracture management in osteopetrosis. When opting for surgical fixation of fractures, there is often a conflict about what implants to use to ensure stable fixation and early functional redemption. Iatrogenic fractures during implant placement, overheating, and drill/saw breakage are some of the difficulties that may arise during surgery. Methods: Our study is a retrospective observational analysis of eight patients with osteopetrosis who underwent surgery for a femur fracture with various types of implants at our facility between January 2010 and March 2022. Following surgery, clinico-radiological follow-ups were done at one, two, six months, 12 months, and then yearly thereafter. Clinically, the patients were assessed based on the Lower Extremity Functional Score (LEFS). Results: The patients who underwent combined extra and intramedullary fixation showed a faster return of LEFS and union time of the fracture. Conclusion: When addressing the fractures in osteopetrosis, it is crucial to consider the risks of fixation in these individuals. Although plate fixation is considered easier, the risk of peri-implant fractures is high. In our experience, intramedullary nailing with plate augmentation and bone grafting provides a much more stable construct which can reduce the risk of further fractures.
- Published
- 2024
- Full Text
- View/download PDF
31. Performance and bone health of broilers reared under artificial lighting and supplemented with different levels of vitamin D3
- Author
-
Tainá Silva Brandão Lopes, Mariana Diniz Costa Vasconcelos, Bruno Teixeira Antunes Costa, Lorena Salim Sousa, Bruno Machado Bertassoli, Natália de Melo Ocarino, Rogéria Serakides, Leonardo José Camargos Lara, and Itallo Conrado Sousa Araújo
- Subjects
bone quality ,broiler chicken ,cholecalciferol ,osteopetrosis ,tibial ,Animal culture ,SF1-1100 - Abstract
ABSTRACT This study aimed to investigate the effects of different levels of vitamin D3 in broiler diets on performance and bone health. A total of 360 one-day old male Cobb500® broiler chicks were subjected to five treatments of different levels of vitamin D3 in diets during two rearing phases: 0 IU/kg in both phases; 625 IU/kg in starter and 500 IU/kg in grower phase (25% of commercial inclusion); 1,250 IU/kg in starter and 1,000 IU/kg in grower phase (50% of commercial inclusion); 1,875 IU/kg in starter and 1,500 IU/kg in grower phase (75% of commercial inclusion); and 2,500 IU/kg in starter and 2,000 IU/kg in grower phase (100% of commercial inclusion). The traits studied weekly were feed intake, body weight, feed conversion, and viability. At 21 and 35 days of age, tibiae and femurs were removed, dissected, and evaluated for dry matter (DM), ash (%MM), calcium (%Ca), phosphorus (%P) and breaking strength. At 35 days of age, the bones were subjected to histopathological analysis for macro- and microscopic morphological evaluation. Data were subjected to regression analysis, using α = 0.05. The variables of percentage %MM, %Ca, %P, and breaking strength experienced a positive linear effect up to the supplementation levels of approximately 25% of inclusion. The histopathological analysis found that the group that received the diet with 100% inclusion of vitamin D3 presented lesions compatible with osteopetrosis and tibial dyschondroplasia. The observed results showed that for isonutritive diets, reduced levels of vitamin D3 guaranteed performance during the evaluated period while the use of 100% of vitamin D3, as commonly used, can cause bone diseases and harm the welfare of broilers.
- Published
- 2024
- Full Text
- View/download PDF
32. Successful complete oral rehabilitation of a patient with osteopetrosis with extensive pre-treatments, bone grafts, dental implants and fixed bridges: a multidisciplinary case report
- Author
-
P. Kelk, A. Fasth, PLif Holgerson, and M. Sjöström
- Subjects
Osteopetrosis ,Hematopoietic stem cell transplantation ,Iliac crest bone graft ,Osseo integrated implants ,Oral rehabilitation ,Dentistry ,RK1-715 - Abstract
Abstract Background Osteopetrosis comprises a group of inherited disorders that are rare and result in abnormal bone structure. Bone remodeling is extremely inhibited because osteoclasts are nonfunctional or lacking. This condition causes overgrowth of bone with disappearance of the bone marrow, leading to aplastic anemia; obstruction of nerve passages in the skull leads to blindness and often hearing impairment. In most cases, osteopetrosis results in oral complications such as tooth deformation, hypomineralization, and delayed or absent tooth eruption. The only curative treatment is hematopoietic stem cell transplantation (HSCT). The main treatment of the oral complications during childhood and adolescence consists in protecting the erupted teeth against caries disease through prophylactic treatment aimed at optimal oral hygiene through frequent regular dental visits throughout life. Many patients with osteopetrosis require major oral rehabilitation to treat complications of the disease. Improved results of HSCT increase the likelihood that dental professionals will encounter patients with osteopetrosis. Case presentation In this case report, we show that individuals with osteopetrosis who have severe oral complications can be treated successfully if they are treated for osteopetrosis at an early age. The boy had his dental care in pedodontics, and regular multidisciplinary meetings were held for future treatment planning. At the age of 15, he was then referred for rehabilitation. The initial evaluations revealed no further growth in the alveolar bone. The rehabilitation was done stepwise, with extraction of malformed and malpositioned teeth. Initially, the patient received a removable partial denture followed by reconstruction of the width of the alveolar process, titanium implants, temporary fixed bridges, and finally screw-retained titanium–ceramic bridges with titanium frames for the upper and lower jaws. Conclusions The three-year follow-up after loading indicated a stable marginal bone level and optimal oral hygiene as a result of frequent professional oral hygiene care. The patient showed no signs of symptoms from the temporomandibular joint and has adapted to the new jaw relation without any functional or phonetical issues.
- Published
- 2023
- Full Text
- View/download PDF
33. Thickness of the hard palate: A new criterion for the diagnosis of osteoporosis?
- Author
-
Kildal, Daniela, Riether, Tobias, Blasenbrey, Tilmann, Turhani, Dritan, Antoch, Gerald, Beer, Meinrad, and Geibel, Margrit-Ann
- Published
- 2024
- Full Text
- View/download PDF
34. Impaired Autophagic Clearance with a Gain-of-Function Variant of the Lysosomal Cl − /H + Exchanger ClC-7.
- Author
-
Bose, Shroddha, de Heus, Cecilia, Kennedy, Mary E., Wang, Fan, Jentsch, Thomas J., Klumperman, Judith, and Stauber, Tobias
- Subjects
- *
ION transport (Biology) , *MEMBRANE fusion , *LYSOSOMES , *OSTEOPETROSIS , *LABORATORY mice - Abstract
ClC-7 is a ubiquitously expressed voltage-gated Cl−/H+ exchanger that critically contributes to lysosomal ion homeostasis. Together with its β-subunit Ostm1, ClC-7 localizes to lysosomes and to the ruffled border of osteoclasts, where it supports the acidification of the resorption lacuna. Loss of ClC-7 or Ostm1 leads to osteopetrosis accompanied by accumulation of storage material in lysosomes and neurodegeneration. Interestingly, not all osteopetrosis-causing CLCN7 mutations from patients are associated with a loss of ion transport. Some rather result in an acceleration of voltage-dependent ClC-7 activation. Recently, a gain-of-function variant, ClC-7Y715C, that yields larger ion currents upon heterologous expression, was identified in two patients with neurodegeneration, organomegaly and albinism. However, neither the patients nor a mouse model that carried the equivalent mutation developed osteopetrosis, although expression of ClC-7Y715C induced the formation of enlarged intracellular vacuoles. Here, we investigated how, in transfected cells with mutant ClC-7, the substitution of this tyrosine impinged on the morphology and function of lysosomes. Combinations of the tyrosine mutation with mutations that either uncouple Cl− from H+ counter-transport or strongly diminish overall ion currents were used to show that increased ClC-7 Cl−/H+ exchange activity is required for the formation of enlarged vacuoles by membrane fusion. Degradation of endocytosed material was reduced in these compartments and resulted in an accumulation of lysosomal storage material. In cells expressing the ClC-7 gain-of-function mutant, autophagic clearance was largely impaired, resulting in a build-up of autophagic material. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. Characterization of Oral Pathology in Cats Affected by Patellar Fracture and Dental Anomaly Syndrome (PADS).
- Author
-
Bell, Cynthia M, Edstrom, Emily, Shope, Bonnie, Carmichael, Daniel, Buelow, Mary, Bailey, Steven J, and Langley-Hobbs, Sorrel J
- Abstract
Patellar fracture and dental anomaly syndrome (PADS) is a congenital bone disease of cats that is characterized by atraumatic bone fractures (most commonly the patella), the persistence of deciduous teeth, and impaction of permanent teeth. Jaw swelling due to osteomyelitis is often the reason that cats with PADS are presented for veterinary dental care. The clinical history, oral examination findings, dental radiological findings, and histopathology were evaluated for 13 cats with dental and skeletal pathology consistent with PADS, including 9 with osteomyelitis. Cats in this study were predominantly domestic shorthair (12 of 13 cats), and there was no apparent sex predilection. All cats had multiple persistent deciduous teeth and multiple impacted permanent teeth, although the number of persistent and impacted teeth varied. Osteomyelitis of the jaw typically occurred within the first 4 years of life. Osteomyelitis of the mandible was 4 times more common than osteomyelitis of the maxilla. Histologically, osteomyelitis was chronic, neutrophilic, and osteoproliferative. Necrotic bone was confirmed in 67% of osteomyelitis lesions. Histological evaluation of jaws without inflammation demonstrated abnormal amounts of unmodeled bone, abnormally dense bone, and retention of cartilage in the caudal mandible. Three cats in the study had mandibular distoclusion and 2 had concurrent paronychia. To obtain a favorable clinical outcome in PADS cats with jaw swelling, prompt and aggressive surgical treatment of osteomyelitis is required. Extraction of persistent deciduous teeth and impacted permanent teeth is recommended when there is associated periodontitis or osteomyelitis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
36. Successful complete oral rehabilitation of a patient with osteopetrosis with extensive pre-treatments, bone grafts, dental implants and fixed bridges: a multidisciplinary case report.
- Author
-
Kelk, P., Fasth, A., Holgerson, PLif, and Sjöström, M.
- Subjects
PROSTHETICS ,DENTAL implants ,DELAYED diagnosis ,PANORAMIC radiography ,OSTEOCLASTS ,ORAL hygiene ,OSTEOPETROSIS ,CHRONICALLY ill ,MANDIBLE ,BRIDGES (Dentistry) ,ALVEOLAR process ,DENTAL care ,TREATMENT effectiveness ,MALOCCLUSION ,DENTAL radiography ,ORAL surgery ,BONE remodeling ,HEMATOPOIETIC stem cell transplantation ,DENTITION ,DENTAL caries ,ORTHOPEDIC apparatus ,BONE grafting ,OSSEOINTEGRATION ,REHABILITATION - Abstract
Background: Osteopetrosis comprises a group of inherited disorders that are rare and result in abnormal bone structure. Bone remodeling is extremely inhibited because osteoclasts are nonfunctional or lacking. This condition causes overgrowth of bone with disappearance of the bone marrow, leading to aplastic anemia; obstruction of nerve passages in the skull leads to blindness and often hearing impairment. In most cases, osteopetrosis results in oral complications such as tooth deformation, hypomineralization, and delayed or absent tooth eruption. The only curative treatment is hematopoietic stem cell transplantation (HSCT). The main treatment of the oral complications during childhood and adolescence consists in protecting the erupted teeth against caries disease through prophylactic treatment aimed at optimal oral hygiene through frequent regular dental visits throughout life. Many patients with osteopetrosis require major oral rehabilitation to treat complications of the disease. Improved results of HSCT increase the likelihood that dental professionals will encounter patients with osteopetrosis. Case presentation: In this case report, we show that individuals with osteopetrosis who have severe oral complications can be treated successfully if they are treated for osteopetrosis at an early age. The boy had his dental care in pedodontics, and regular multidisciplinary meetings were held for future treatment planning. At the age of 15, he was then referred for rehabilitation. The initial evaluations revealed no further growth in the alveolar bone. The rehabilitation was done stepwise, with extraction of malformed and malpositioned teeth. Initially, the patient received a removable partial denture followed by reconstruction of the width of the alveolar process, titanium implants, temporary fixed bridges, and finally screw-retained titanium–ceramic bridges with titanium frames for the upper and lower jaws. Conclusions: The three-year follow-up after loading indicated a stable marginal bone level and optimal oral hygiene as a result of frequent professional oral hygiene care. The patient showed no signs of symptoms from the temporomandibular joint and has adapted to the new jaw relation without any functional or phonetical issues. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
37. Case Report: Osteosclerotic metaphyseal dysplasia with optic nerve involvement and progressive osteonecrosis of the jaw due to a novel LRRK1 mutation.
- Author
-
Pieridou, Chariklia, Sabir, Ataf, Lancashire, Jonathan, Yifan Liang, McMillan, Kevin, Shaw, Nick, and Uday, Suma
- Subjects
DYSPLASIA ,OPTIC nerve ,HEMATOPOIETIC stem cell transplantation ,OSTEONECROSIS ,OSTEOPETROSIS ,GENETIC testing - Abstract
Background: Osteosclerotic metaphyseal dysplasia (OSMD, OMIM 615198) is an extremely rare autosomal recessive osteopetrosis disorder resulting in a distinctive pattern of osteosclerosis of the metaphyseal margins of long tubular bones. To date, only thirteen cases have been reported (eight molecularly confirmed). Five homozygous sequence variants in the leucine-rich repeat kinase 1 (LRRK1) gene have been identified to cause OSMD. We present two male siblings with OSMD with a novel LRRK1 variant. Cases: The index case, now aged 6 years, was referred aged 9 months when diffuse sclerosis of the ribs and vertebral bodies, suggestive of osteopetrosis, was incidentally identified on a chest radiograph for suspected lower respiratory tract infection. Parents were consanguineous and of Pakistani origin. Further evaluation revealed developmental delay, nystagmus with bilateral optic nerve hypoplasia and severe visual impairment. Skeletal survey confirmed typical changes of OSMD, with widespread diffuse sclerosis and Erlenmeyer flask deformity of long bones. His older sibling, now aged 12 years, was 7 years at the time of referral and had similar clinical course and skeletal findings. Additionally, he had a chronic progressive osteonecrosis of the left mandible that required debridement, debulking and long-term antibiotics. Skeletal survey revealed findings similar to his sibling. Neither sibling had significant skeletal fractures or seizures. Unlike most previous reports suggesting sparing of the skull and lack of visual impairment, our patients had evidence of osteosclerosis of the cranium. Genetic screening for the common autosomal recessive and dominant pathogenic variants of osteopetrosis was negative. Whole Exome Sequencing (WES) followed by Sanger sequencing, identified a novel homozygous LRRK1 c.2506C>T p. (Gln836Ter) nonsense variant predicted to result in premature truncation of LRRK1 transcript. Conclusion: Our cases confirm the autosomal recessive inheritance and expand the spectrum of genotype and phenotype of OSMD reported in the literature. Increasing reports of LRRK1 variants in this phenotype raise the question of whether LRRK1 should be included in targeted osteopetrosis panels. Bone histology in previous cases has shown this to be an osteoclast rich form of osteopetrosis raising the possibility that haematopoietic stem cell transplantation may be an appropriate treatment modality. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
38. Defects in Bone and Bone Marrow in Inherited Anemias: the Chicken or the Egg.
- Author
-
Willimann, Rachel, Chougar, Christina, Wolfe, Lawrence C., Blanc, Lionel, and Lipton, Jeffrey M.
- Abstract
Purpose of Review: Recently, there has been an increasing number of studies on the crosstalk between the bone and the bone marrow and how it pertains to anemia. Here, we discuss four heritable clinical syndromes contrasting those in which anemia affects bone growth and development, with those in which abnormal bone development results in anemia, highlighting the multifaceted interactions between skeletal development and hematopoiesis. Recent Findings: Anemia results from both inherited and acquired disorders caused by either impaired production or premature destruction of red blood cells or blood loss. The downstream effects on bone development and growth in patients with anemia often constitute an important part of their clinical condition. We will discuss the interdependence of abnormal bone development and growth and hematopoietic abnormalities, with a focus on the erythroid lineage. To illustrate those points, we selected four heritable anemias that arise from either defective hematopoiesis impacting the skeletal system (the hemoglobinopathies β-thalassemia and sickle cell disease) versus defective osteogenesis resulting in impaired hematopoiesis (osteopetrosis). Finally, we will discuss recent findings in Diamond Blackfan anemia, an intrinsic disorder of both the erythron and the bone. Summary: By focusing on four representative hereditary hematopoietic disorders, this complex relationship between bone and blood should lead to new areas of research in the field. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
39. Osteomyelitis Developing in Fracture After Tooth Extraction in the Mandible of Patient with Osteopetrosis.
- Author
-
BAĞCI, Nuray and ÜÇOK, Cemile Özlem
- Subjects
DENTAL extraction ,OSTEOPETROSIS ,TOOTH fractures ,MANDIBLE ,OSTEOMYELITIS ,MANDIBULAR fractures ,PAIN clinics - Abstract
Copyright of Turkiye Klinikleri Journal of Dental Sciences is the property of Turkiye Klinikleri and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
40. Periorbital Bony Diseases
- Author
-
Chow, Shuk Wan Joyce, POON, Tak Lap, editor, MAK, Calvin, editor, and YUEN, Hunter Kwok Lai, editor
- Published
- 2023
- Full Text
- View/download PDF
41. A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis
- Author
-
California Institute for Regenerative Medicine (CIRM)
- Published
- 2022
42. Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
- Published
- 2022
43. MUTATION IN THE CLCN7 GENE CAUSING AUTOSOMAL DOMINANT OSTEOPETROSIS TYPE Ⅱ: A CASE REPORT AND LITERATURE REVIEW
- Author
-
LIU Xueting, WANG Shuangyi
- Subjects
osteopetrosis ,genetic testing ,clcn7 gene ,mutation ,case reports ,Medicine - Abstract
Objective To analyze the mutation in the CLCN7 gene in a patient with autosomal dominant osteopetrosis type Ⅱ (ADOⅡ), and to improve clinical understanding of the disease. Methods The clinical data of a patient with ADOⅡ were collected, and the peripheral blood samples of the patient and his wife and daughter were collected. The exons in the CLCN7 gene were amplified using polymerase chain reaction (PCR). The products from the PCR amplification were purified, sequenced, and screened for mutation sites. Results The patient’s lower left posterior tooth region was swollen and painful, and the effect of anti-inflammatory treatment was not satisfactory. After admission, a curettage surgery for the left mandibular osteomyelitis combined with dead bone removal was performed under general anesthesia. During the surgery, the granulation tissue and dead bones in the left mandible diseased area were submitted for examination. The pathological diagnosis showed (mandibular bone marrow) chronic suppurative inflammation with granulation tissue proliferation and dead bone formation in the mandible. Gene testing revealed a missense mutation in exon 24 of the CLCN7 gene, namely the p.Arg743Trp mutation. After surgery, fluid infusion and anti-infective treatment were given. Upon discharge, the patient had a good general condition, with no swelling or pain in the left mandibular area; the incisions in the mouth healed well, and showing no bleeding. Conclusion The missense mutation of p.Arg743Trp in the CLCN7 gene can lead to ADOⅡ. This study can provide reference for genetic diagnosis and treatment of ADOⅡ in the local population in the future.
- Published
- 2023
- Full Text
- View/download PDF
44. Clinical, genetic aspects and molecular pathogenesis of osteopetrosis
- Author
-
D. D. Nadyrshina and R. I. Khusainova
- Subjects
osteopetrosis ,classification ,connective tissue ,Genetics ,QH426-470 - Abstract
Osteopetrosis (“marble bone”, ICD-10-78.2) includes a group of hereditary bone disorders distinguished by clinical variability and genetic heterogeneity. The name “osteopetrosis” comes from the Greek language: ‘osteo’ means ‘bone’ and ‘petrosis’ means ‘stone’, which characterizes the main feature of the disease: increased bone density caused by imbalances in bone formation and remodeling, leading to structural changes in bone tissue, predisposition to fractures, skeletal deformities. These defects, in turn, affect other important organs and tissues, especially bone marrow and the nervous system. The disease can be autosomal recessive, autosomal dominant, X-linked or sporadic. Autosomal dominant osteopetrosis has an incidence of 1 in 20,000 newborns and autosomal recessive one has 1 in 250,000. To date, 23 genes have been described, structural changes in which lead to the development of osteopetrosis. Clinical symptoms in osteopetrosis vary greatly in their presentation and severity. The mildest skeletal abnormalities are observed in adulthood and occur in the autosomal dominant form of osteopetrosis. Severe forms, being autosomal recessive and manifesting in early childhood, are characterized by fractures, mental retardation, skin lesions, immune system disorders, renal tubular acidosis. Clinical examination and review of radiographs, bone biopsy and genetic testing provide the bases for clinical diagnosis. The early and accurate detection and treatment of the disease are important to prevent hematologic abnormalities and disease progression to irreversible neurologic consequences. Most patients die within the first decade due to secondary infections, bone marrow suppression and/or bleeding. This article summarizes the current state of the art in this field, including clinical and genetic aspects, and the molecular pathogenesis of the osteopetrosis.
- Published
- 2023
- Full Text
- View/download PDF
45. T-cell Depleted Alternative Donor Transplantation
- Published
- 2022
46. Sclerostin Depletion Induces Inflammation in the Bone Marrow of Mice.
- Author
-
Donham, Cristine, Chicana, Betsabel, Robling, Alexander G, Mohamed, Asmaa, Elizaldi, Sonny, Chi, Michael, Freeman, Brian, Millan, Alberto, Murugesh, Deepa K, Hum, Nicholas R, Sebastian, Aimy, Loots, Gabriela G, and Manilay, Jennifer O
- Subjects
aging ,genetic animal models ,osteoimmunology ,osteopetrosis ,Chemical Physics ,Other Chemical Sciences ,Genetics ,Other Biological Sciences - Abstract
Romosozumab, a humanized monoclonal antibody specific for sclerostin (SOST), has been approved for treatment of postmenopausal women with osteoporosis at a high risk for fracture. Previous work in sclerostin global knockout (Sost-/-) mice indicated alterations in immune cell development in the bone marrow (BM), which could be a possible side effect in romosozumab-treated patients. Here, we examined the effects of short-term sclerostin depletion in the BM on hematopoiesis in young mice receiving sclerostin antibody (Scl-Ab) treatment for 6 weeks, and the effects of long-term Sost deficiency on wild-type (WT) long-term hematopoietic stem cells transplanted into older cohorts of Sost-/- mice. Our analyses revealed an increased frequency of granulocytes in the BM of Scl-Ab-treated mice and WT→Sost-/- chimeras, indicating myeloid-biased differentiation in Sost-deficient BM microenvironments. This myeloid bias extended to extramedullary hematopoiesis in the spleen and was correlated with an increase in inflammatory cytokines TNFα, IL-1α, and MCP-1 in Sost-/- BM serum. Additionally, we observed alterations in erythrocyte differentiation in the BM and spleen of Sost-/- mice. Taken together, our current study indicates novel roles for Sost in the regulation of myelopoiesis and control of inflammation in the BM.
- Published
- 2021
47. Fluconazole-Induced Protein Changes in Osteogenic and Immune Metabolic Pathways of Dental Pulp Mesenchymal Stem Cells of Osteopetrosis Patients.
- Author
-
Alkhayal, Zikra, Shinwari, Zakia, Gaafar, Ameera, and Alaiya, Ayodele
- Subjects
- *
MESENCHYMAL stem cells , *BONE morphogenetic proteins , *DENTAL pulp , *OSTEOPETROSIS , *BONE regeneration , *CARBONIC anhydrase - Abstract
Osteopetrosis is a rare inherited disease caused by osteoclast failure, resulting in increasing bone density in humans. Patients with osteopetrosis possess several dental and cranial complications. Since carbonic anhydrase II (CA-II) deficiency is a major cause of osteopetrosis, CA-II activators might be an attractive potential treatment option for osteopetrosis patients. We conducted comprehensive label-free quantitative proteomics analysis on Fluconazole-treated Dental Pulp Mesenchymal Stem/Stromal Cells from CA-II-Deficient Osteopetrosis Patients. We identified 251 distinct differentially expressed proteins between healthy subjects, as well as untreated and azole-treated derived cells from osteopetrosis patients. Twenty-six (26) of these proteins were closely associated with osteogenesis and osteopetrosis disease. Among them are ATP1A2, CPOX, Ap2 alpha, RAP1B and some members of the RAB protein family. Others include AnnexinA1, 5, PYGL, OSTF1 and PGAM4, all interacting with OSTM1 in the catalytic reactions of HCO3 and the Cl- channel via CAII regulation. In addition, the pro-inflammatory/osteoclast regulatory proteins RACK1, MTSE, STING1, S100A13, ECE1 and TRIM10 are involved. We have identified proteins involved in osteogenic and immune metabolic pathways, including ERK 1/2, phosphatase and ATPase, which opens the door for some CA activators to be used as an alternative drug therapy for osteopetrosis patients. These findings propose that fluconazole might be a potential treatment agent for CAII- deficient OP patients. Altogether, our findings provide a basis for further work to elucidate the clinical utility of azole, a CA activator, as a therapeutic for OP. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
48. Les anomalies hématologiques et cytologiques observées au cours de l'ostéopétrose maligne infantile.
- Author
-
Puyraimond, Sandrine, Simon, Pauline, Roggy, Anne, Mathieu, Valérie, Lejarre, Fabien, and Ottou, Francine Garnache
- Abstract
L'ostéopétrose maligne infantile se caractérise par une densification osseuse anormale et excessive résultant d'un dysfonctionnement des ostéoclastes. Elle se manifeste, dès les premiers mois de vie, par un retentissement sur le squelette, des troubles neuro-sensoriels, des anomalies orthodontiques, du système nerveux et de l'hématopoïèse. Son diagnostic repose sur des critères cliniques, radiologiques, biologiques et génétiques. Le cytologiste est impliqué dans la démarche diagnostique par la recherche des anomalies quantitatives de la numération formule sanguine et morphologiques du frottis sanguin et du myélogramme. Maladie grave et létale, son traitement repose sur la greffe de cellules hématopoïétiques. Malignant osteopetrosis in children is characterized by abnormal and excessive bone densification resulting from osteoclast dysfunction. It manifests itself, from the first months of life, by a repercussion on the skeleton, neurosensory disorders, orthodental anomalies, nervous system and hematopoiesis. Its diagnosis is based on clinical, radiological, biological and genetic criteria. The cytologist is involved in the diagnostic process by looking for quantitative abnormalities of the blood count and morphological abnormalities of the blood smear and the bone marrow aspiration. A serious and lethal disease, its treatment is based on hematopoietic cell transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
49. Multiple oral sinus tract and trismus leading to a surprising diagnosis of osteopetrosis: Case report.
- Author
-
Pinheiro, Tiago Novaes, Desideri Vieira, Ana Julia, Salino, Alessandra Valle, de Oliveira Aranha Ribeiro, Eliane, Felipe do Vale, Hugo, de Souza Leitão, Rodrigo, Carlos, Roman, and Tavares Ângelo Cintra, Luciano
- Subjects
OSTEOPETROSIS ,TRISMUS ,MEDICAL care ,DELAYED diagnosis ,COMPUTED tomography ,DENTAL extraction - Abstract
Aims: We report a rare case of late diagnosis of malignant osteopetrosis in a 36‐year‐old male patient due to multiple intraoral sinus tracts and trismus. Case Report: The patient reported a history of facial scars that could not be attributed to the older external fistulas that were present and various complicated dental extractions since infancy. In addition, the patient had not been previously diagnosed with any other significant diseases other than blindness since infancy. Computed tomography revealed a marble‐like sclerotic pattern of all cranial bones, a thickened parietal bone, and a narrowing of the encephalic space and the optic canal. Further laboratory and imaging studies revealed complete sclerosed bone of the chest and pelvis, anemia, reticulocitosis, extramedular hematopoiesis, altered dehydrogenasis lactate, and acid phosphatasis. An interdisciplinary treatment was initiated with medical and dental care monitoring. The patient is still receiving attention after 4 years of follow‐up. Conclusions: The outcome of this case represents the daily challenges faced by interdisciplinary care providers and reveals pearls and pitfalls that can serve as a reference for professional practice in such cases. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
50. Clinical and Osteopetrosis-Like Radiological Findings in Patients with Leukocyte Adhesion Deficiency Type III.
- Author
-
Kahraman, Ayca Burcu, Yaz, Ismail, Gocmen, Rahsan, Aytac, Selin, Metin, Ayse, Kilic, Sara Sebnem, Tezcan, Ilhan, and Cagdas, Deniz
- Subjects
- *
HEMATOPOIETIC stem cell transplantation , *BLOOD platelet disorders , *OTITIS media , *LEUCOCYTES , *LEUKOCYTE count , *BONE resorption , *CYTOSKELETON - Abstract
Background: Leukocyte and platelet integrin function defects are present in leukocyte adhesion deficiency type III (LAD-III) due to mutations in FERMT3. Additionally, osteoclast/osteoblast dysfunction develops in LAD-III. Aim: To discuss the distinguishing clinical, radiological, and laboratory features of LAD-III. Methods: This study included the clinical, radiological, and laboratory characteristics of twelve LAD-III patients. Results: The male/female ratio was 8/4. The parental consanguinity ratio was 100%. Half of the patients had a family history of patients with similar findings. The median age at presentation and diagnosis was 18 (1–60) days and 6 (1–20) months, respectively. The median leukocyte count on admission was 43,150 (30,900–75,700)/μL. The absolute eosinophil count was tested in 8/12 patients, and eosinophilia was found in 6/8 (75%). All patients had a history of sepsis. Other severe infections were pneumonia (66.6%), omphalitis (25%), osteomyelitis (16.6%), gingivitis/periodontitis (16%), chorioretinitis (8.3%), otitis media (8.3%), diarrhea (8.3%), and palpebral conjunctiva infection (8.3%). Four patients (33.3%) received hematopoietic stem cell transplantation (HSCT) from HLA-matched-related donors, and one deceased after HSCT. At initial presentation, 4 (33.3%) patients were diagnosed with other hematologic disorders, three patients (P5, P7, and P8) with juvenile myelomonocytic leukemia (JMML), and one (P2) with myelodysplastic syndrome (MDS). Conclusion: In LAD-III, leukocytosis, eosinophilia, and bone marrow findings may mimic pathologies such as JMML and MDS. In addition to non-purulent infection susceptibility, patients with LAD-III exhibit Glanzmann-type bleeding disorder. In LAD-III, absent integrin activation due to kindlin-3 deficiency disrupts osteoclast actin cytoskeleton organization. This results in defective bone resorption and osteopetrosis-like radiological changes. These are distinctive features compared to other LAD types. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.